4CPS-157 Vedolizumab: early experience and medium-term outcomes in inflammatory bowel disease

L Pedraza Nieto; R Fernández Caballero; JG Sánchez-Hernández; N Rebollo; MC Piñero Pérez; D García González; EM Sáez Fernández; MJ Otero López

doi:10.1136/ejhpharm-2018-eahpconf.248

Article info

Section 4: Clinical pharmacy services

4CPS-157 Vedolizumab: early experience and medium-term outcomes in inflammatory bowel disease

Authors

L Pedraza Nieto 1Complejo Asistencial Universitario de Salamanca, Servicio de Farmacia, Salamanca, Spain PubMed articles Google scholar articles
R Fernández Caballero 1Complejo Asistencial Universitario de Salamanca, Servicio de Farmacia, Salamanca, Spain PubMed articles Google scholar articles
JG Sánchez-Hernández 1Complejo Asistencial Universitario de Salamanca, Servicio de Farmacia, Salamanca, Spain PubMed articles Google scholar articles
N Rebollo 1Complejo Asistencial Universitario de Salamanca, Servicio de Farmacia, Salamanca, Spain PubMed articles Google scholar articles
MC Piñero Pérez 2Complejo Asistencial Universitario de Salamanca, Servicio de Aparato Digestivo, Salamanca, Spain PubMed articles Google scholar articles
D García González 1Complejo Asistencial Universitario de Salamanca, Servicio de Farmacia, Salamanca, Spain PubMed articles Google scholar articles
EM Sáez Fernández 1Complejo Asistencial Universitario de Salamanca, Servicio de Farmacia, Salamanca, Spain PubMed articles Google scholar articles
MJ Otero López 1Complejo Asistencial Universitario de Salamanca, Servicio de Farmacia, Salamanca, Spain PubMed articles Google scholar articles

Citation

Nieto LP, Caballero RF, Sánchez-Hernández J, et al

4CPS-157 Vedolizumab: early experience and medium-term outcomes in inflammatory bowel disease

European Journal of Hospital Pharmacy 2018;25:A115-A116.

Publication history

First published March 2, 2018.

Online issue publication

April 21, 2018

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Main menu

Authors

Citation

Publication history

Request permissions

Copyright information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password